Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/BRL-32872> ?p ?o }
Showing triples 1 to 59 of
59
with 100 triples per page.
- BRL-32872 abstract "BRL-32872 is an experimental drug candidate that provides a novel approach to the treatment of cardiac arrhythmia. Being a derivative of verapamil, it possesses the ability to inhibit Ca+2 membrane channels. Specific modifications in hydrogen bonding activity, nitrogen lone pair availability, and molecular flexibility allow BRL-32872 to inhibit K+ channels as well. As such, BRL-32872 is classified as both a class III (K+ blocking) and class IV (Ca+2 blocking) antiarrhythmic agent.".
- BRL-32872 iupacName "N-(3,4-Dimethoxyphenyl)-N-(3-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}propyl)-4-nitrobenzamide".
- BRL-32872 thumbnail BRL-32872.svg?width=300.
- BRL-32872 wikiPageID "30854460".
- BRL-32872 wikiPageLength "7748".
- BRL-32872 wikiPageOutDegree "18".
- BRL-32872 wikiPageRevisionID "670371569".
- BRL-32872 wikiPageWikiLink Acidosis.
- BRL-32872 wikiPageWikiLink Action_potential.
- BRL-32872 wikiPageWikiLink Antiarrhythmic_agent.
- BRL-32872 wikiPageWikiLink Bradycardia.
- BRL-32872 wikiPageWikiLink Cardiac_arrhythmia.
- BRL-32872 wikiPageWikiLink Cardiac_rhythmicity.
- BRL-32872 wikiPageWikiLink Category:Antiarrhythmic_agents.
- BRL-32872 wikiPageWikiLink Electrolyte.
- BRL-32872 wikiPageWikiLink Fibrillation.
- BRL-32872 wikiPageWikiLink HERG.
- BRL-32872 wikiPageWikiLink Hydrochloride.
- BRL-32872 wikiPageWikiLink Hydrogen_bond.
- BRL-32872 wikiPageWikiLink Hydrogen_bonding.
- BRL-32872 wikiPageWikiLink Hypoxia_(medical).
- BRL-32872 wikiPageWikiLink Ischemia.
- BRL-32872 wikiPageWikiLink Lone_pair.
- BRL-32872 wikiPageWikiLink Membrane_channel.
- BRL-32872 wikiPageWikiLink Tachycardia.
- BRL-32872 wikiPageWikiLink Verapamil.
- BRL-32872 hasPhotoCollection BRL-32872.
- BRL-32872 imagefile "BRL-32872.svg".
- BRL-32872 imagesize "200".
- BRL-32872 iupacname "N--N--4-nitrobenzamide".
- BRL-32872 verifiedfields "changed".
- BRL-32872 verifiedrevid "458978130".
- BRL-32872 watchedfields "changed".
- BRL-32872 wikiPageUsesTemplate Template:Chembox.
- BRL-32872 wikiPageUsesTemplate Template:Orphan.
- BRL-32872 wikiPageUsesTemplate Template:Reflist.
- BRL-32872 subject Category:Antiarrhythmic_agents.
- BRL-32872 hypernym Candidate.
- BRL-32872 type Agent.
- BRL-32872 type ChemicalCompound.
- BRL-32872 type ChemicalSubstance.
- BRL-32872 type Drug.
- BRL-32872 type Person.
- BRL-32872 type Agent.
- BRL-32872 type Chemical.
- BRL-32872 type Drug.
- BRL-32872 type ChemicalObject.
- BRL-32872 type Thing.
- BRL-32872 type Q11173.
- BRL-32872 comment "BRL-32872 is an experimental drug candidate that provides a novel approach to the treatment of cardiac arrhythmia. Being a derivative of verapamil, it possesses the ability to inhibit Ca+2 membrane channels. Specific modifications in hydrogen bonding activity, nitrogen lone pair availability, and molecular flexibility allow BRL-32872 to inhibit K+ channels as well. As such, BRL-32872 is classified as both a class III (K+ blocking) and class IV (Ca+2 blocking) antiarrhythmic agent.".
- BRL-32872 label "BRL-32872".
- BRL-32872 sameAs m.0gfj25q.
- BRL-32872 sameAs BRL-32872.
- BRL-32872 sameAs BRL-32872.
- BRL-32872 sameAs Q4836374.
- BRL-32872 sameAs Q4836374.
- BRL-32872 wasDerivedFrom BRL-32872?oldid=670371569.
- BRL-32872 depiction BRL-32872.svg.
- BRL-32872 isPrimaryTopicOf BRL-32872.